Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Identification and Structure–Activity Relationships of Novel Compounds that Potentiate the Activities of Antibiotics in Escherichia coli

Journal Article · · Journal of Medicinal Chemistry
 [1];  [2];  [2];  [2];  [3];  [3];  [4];  [2];  [4];  [5]
  1. Saint Louis Univ., St. Louis, MO (United States). School of Medicine. Dept. of Pharmacological and Physiological Science
  2. Univ. of Oklahoma, Norman, OK (United States). Dept. of Chemistry and Biochemistry
  3. Oak Ridge National Lab. (ORNL), Oak Ridge, TN (United States). Biosciences Division. UT/ORNL Center for Molecular Biophysics; Univ. of Tennessee, Knoxville, TN (United States). Graduate School of Genome Science and Technology
  4. Oak Ridge National Lab. (ORNL), Oak Ridge, TN (United States). Biosciences Division. UT/ORNL Center for Molecular Biophysics; Univ. of Tennessee, Knoxville, TN (United States). Dept. of Biochemistry and Cellular and Molecular Biology
  5. Saint Louis Univ., St. Louis, MO (United States). School of Medicine. Dept. of Pharmacological and Physiological Science. Dept. of Chemistry
In Gram-negative bacteria, efflux pumps are able to prevent effective cellular concentrations from being achieved for a number of antibiotics. Small molecule adjuvants that act as efflux pump inhibitors (EPIs) have the potential to reinvigorate existing antibiotics that are currently ineffective due to efflux mechanisms. Through a combination of rigorous experimental screening and in silico virtual screening, we recently identified novel classes of EPIs that interact with the membrane fusion protein AcrA, a critical component of the AcrAB-TolC efflux pump in Escherichia coli. In this paper, we present initial optimization efforts and structure–activity relationships around one of those previously described hits, NSC 60339 (1). Finally, from these efforts we identified two compounds, SLUPP-225 (17h) and SLUPP-417 (17o), which demonstrate favorable properties as potential EPIs in E. coli cells including the ability to penetrate the outer membrane, improved inhibition of efflux relative to 1, and potentiation of the activity of novobiocin and erythromycin.
Research Organization:
Oak Ridge National Lab. (ORNL), Oak Ridge, TN (United States); Saint Louis Univ., St. Louis, MO (United States); Univ. of Oklahoma, Norman, OK (United States)
Sponsoring Organization:
National Inst. of Health (NIH) (United States); USDOE; Univ. of Saint Louis School of Medicine (United States)
Contributing Organization:
Univ. of Tennessee, Knoxville, TN (United States)
Grant/Contract Number:
AC05-00OR22725
OSTI ID:
1376432
Journal Information:
Journal of Medicinal Chemistry, Journal Name: Journal of Medicinal Chemistry Journal Issue: 14 Vol. 60; ISSN 0022-2623
Publisher:
American Chemical Society (ACS)Copyright Statement
Country of Publication:
United States
Language:
English

References (34)

VinaMPI: Facilitating multiple receptor high-throughput virtual docking on high-performance computers: Software News And Updates journal June 2013
AcrA is a highly asymmetric protein capable of spanning the periplasm 1 1Edited by I. B. Holland journal January 1999
Outer membrane permeability and antibiotic resistance journal May 2009
Activity of diimidazoline amides against African trypanosomiasis journal February 2014
Collapsing the Proton Motive Force to Identify Synergistic Combinations against Staphylococcus aureus journal September 2013
Prospects for the next anti-Pseudomonas drug journal October 2009
Conformational Flexibility in the Multidrug Efflux System Protein AcrA journal March 2006
Pseudoatomic Structure of the Tripartite Multidrug Efflux Pump AcrAB-TolC Reveals the Intermeshing Cogwheel-like Interaction between AcrA and TolC journal February 2016
Reviving Antibiotics: Efflux Pump Inhibitors That Interact with AcrA, a Membrane Fusion Protein of the AcrAB-TolC Multidrug Efflux Pump journal November 2016
New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays journal April 2010
Multi-Conformer Ensemble Docking to Difficult Protein Targets journal August 2014
Crystal structure of the CusBA heavy-metal efflux complex of Escherichia coli journal February 2011
Structural basis for the inhibition of bacterial multidrug exporters journal June 2013
Structure of the AcrAB–TolC multidrug efflux pump journal April 2014
Predictive compound accumulation rules yield a broad-spectrum antibiotic journal May 2017
Kinetic control of TolC recruitment by multidrug efflux complexes journal September 2009
Multidrug binding properties of the AcrB efflux pump characterized by molecular dynamics simulations journal November 2012
AcrB drug-binding pocket substitution confers clinically relevant resistance and altered substrate specificity journal March 2015
Molecular basis for inhibition of AcrB multidrug efflux pump by novel and powerful pyranopyridine derivatives journal March 2016
Mild and Efficient One-Pot Synthesis of 2-Imidazolines from Nitriles Using Sodium Hydrosulfide as Catalyst journal August 2008
A 96-well plate fluorescence assay for assessment of cellular permeability and active efflux in Salmonella enterica serovar Typhimurium and Escherichia coli journal May 2010
Broad-specificity efflux pumps and their role in multidrug resistance of Gram-negative bacteria journal March 2012
On the role of TolC in multidrug efflux: the function and assembly of AcrAB-TolC tolerate significant depletion of intracellular TolC protein: Role of TolC in multidrug efflux journal January 2013
Breaking the permeability barrier of Escherichia coli by controlled hyperporination of the outer membrane. journal October 2016
Novel Piperazine Arylideneimidazolones Inhibit the AcrAB-TolC Pump in Escherichia coli and Simultaneously Act as Fluorescent Membrane Probes in a Combined Real-Time Influx and Efflux Assay journal April 2016
Identification and Characterization of Inhibitors of Multidrug Resistance Efflux Pumps in Pseudomonas aeruginosa: Novel Agents for Combination Therapy journal January 2001
AcrAB Efflux System: Expression and Contribution to Fluoroquinolone Resistance in Klebsiella spp journal December 2002
The AcrAB-TolC Pump Is Involved in Macrolide Resistance but Not in Telithromycin Efflux in Enterobacter aerogenes and Escherichia coli journal September 2004
Chimeric Analysis of the Multicomponent Multidrug Efflux Transporters from Gram-Negative Bacteria journal December 2002
Functional Relevance of AcrB Trimerization in Pump Assembly and Substrate Binding journal February 2014
Modern Therapeutic Approaches Against Pseudomonas aeruginosa Infections journal April 2015
Multidrug Efflux in Pseudomonas aeruginosa Components, Mechanisms and Clinical Significance journal May 2001
Recent advances toward a molecular mechanism of efflux pump inhibition journal May 2015
An overview of bacterial efflux pumps and computational approaches to study efflux pump inhibitors journal February 2016

Cited By (6)

Retrospective ensemble docking of allosteric modulators in an adenosine G-protein-coupled receptor journal August 2020
Quantifying the Evolutionary Conservation of Genes Encoding Multidrug Efflux Pumps in the ESKAPE Pathogens To Identify Antimicrobial Drug Targets journal April 2018
1,2,4-Oxadiazole/2-Imidazoline Hybrids: Multi-target-directed Compounds for the Treatment of Infectious Diseases and Cancer journal April 2019
Efflux pump inhibitors for bacterial pathogens: From bench to bedside journal January 2019
Spectrofluorimetric quantification of antibiotic drug concentration in bacterial cells for the characterization of translocation across bacterial membranes journal May 2018
Antibiotic adjuvants: an alternative approach to overcome multi-drug resistant Gram-negative bacteria journal April 2019

Similar Records

Discovery of multidrug efflux pump inhibitors with a novel chemical scaffold
Journal Article · Mon Feb 03 19:00:00 EST 2020 · Biochimica et Biophysica Acta - General Subjects · OSTI ID:1606783

Mechanistic Duality of Bacterial Efflux Substrates and Inhibitors: Example of Simple Substituted Cinnamoyl and Naphthyl Amides
Journal Article · Tue Aug 10 20:00:00 EDT 2021 · ACS Infectious Diseases · OSTI ID:1820794